Relapses in the Guillain-Barre syndrome after treatment with intravenous immune globulin or plasma exchange

J. G. Romano; F. T. Rotta; P. Potter; V. Rosenfeld; R. Santibanez; B. Rocha; W. G. Bradley

doi:10.1002/(SICI)1097-4598(199810)21:10<1327::AID-MUS14>3.0.CO;2-Z

Relapses in the Guillain-Barre syndrome after treatment with intravenous immune globulin or plasma exchange

J. G. Romano, F. T. Rotta, P. Potter, V. Rosenfeld, R. Santibanez, B. Rocha, W. G. Bradley

Neurology

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Abstract

To clarify the question of whether Guillain-Barre syndrome (GBS) patients treated with intravenous immune globulin (IVIG) relapse at a higher frequency than those treated with plasma exchange (PE), 54 patients with GBS were studied retrospectively. A higher frequency of relapses was noted in the PE-treated patients than in those receiving IVIG. The presence of an associated medical condition correlated with an increased risk of relapses, while earlier onset of treatment resulted in a decrease of relapses of GBS. This study found no support for prior suggestions of increased relapses in patients with GBS treated with IVIG as opposed to those treated with PE.

Original language	English (US)
Pages (from-to)	1327-1330
Number of pages	4
Journal	Muscle and Nerve
Volume	21
Issue number	10
DOIs	https://doi.org/10.1002/(SICI)1097-4598(199810)21:10<1327::AID-MUS14>3.0.CO;2-Z
State	Published - Sep 12 1998

Keywords

Guillain-Barre syndrome
Intravenous immune globulin
Plasma exchange
Relapses

ASJC Scopus subject areas

Clinical Neurology
Neuroscience(all)

Access to Document

10.1002/(SICI)1097-4598(199810)21:10<1327::AID-MUS14>3.0.CO;2-Z

Fingerprint Dive into the research topics of 'Relapses in the Guillain-Barre syndrome after treatment with intravenous immune globulin or plasma exchange'. Together they form a unique fingerprint.

Cite this

@article{0da809cddd8344a3bb1b627ad689db32,

title = "Relapses in the Guillain-Barre syndrome after treatment with intravenous immune globulin or plasma exchange",

abstract = "To clarify the question of whether Guillain-Barre syndrome (GBS) patients treated with intravenous immune globulin (IVIG) relapse at a higher frequency than those treated with plasma exchange (PE), 54 patients with GBS were studied retrospectively. A higher frequency of relapses was noted in the PE-treated patients than in those receiving IVIG. The presence of an associated medical condition correlated with an increased risk of relapses, while earlier onset of treatment resulted in a decrease of relapses of GBS. This study found no support for prior suggestions of increased relapses in patients with GBS treated with IVIG as opposed to those treated with PE.",

keywords = "Guillain-Barre syndrome, Intravenous immune globulin, Plasma exchange, Relapses",

author = "Romano, {J. G.} and Rotta, {F. T.} and P. Potter and V. Rosenfeld and R. Santibanez and B. Rocha and Bradley, {W. G.}",

year = "1998",

month = sep,

day = "12",

doi = "10.1002/(SICI)1097-4598(199810)21:10<1327::AID-MUS14>3.0.CO;2-Z",

language = "English (US)",

volume = "21",

pages = "1327--1330",

journal = "Muscle and Nerve",

issn = "0148-639X",

publisher = "John Wiley and Sons Inc.",

number = "10",

}

TY - JOUR

T1 - Relapses in the Guillain-Barre syndrome after treatment with intravenous immune globulin or plasma exchange

AU - Romano, J. G.

AU - Rotta, F. T.

AU - Potter, P.

AU - Rosenfeld, V.

AU - Santibanez, R.

AU - Rocha, B.

AU - Bradley, W. G.

PY - 1998/9/12

Y1 - 1998/9/12

N2 - To clarify the question of whether Guillain-Barre syndrome (GBS) patients treated with intravenous immune globulin (IVIG) relapse at a higher frequency than those treated with plasma exchange (PE), 54 patients with GBS were studied retrospectively. A higher frequency of relapses was noted in the PE-treated patients than in those receiving IVIG. The presence of an associated medical condition correlated with an increased risk of relapses, while earlier onset of treatment resulted in a decrease of relapses of GBS. This study found no support for prior suggestions of increased relapses in patients with GBS treated with IVIG as opposed to those treated with PE.

AB - To clarify the question of whether Guillain-Barre syndrome (GBS) patients treated with intravenous immune globulin (IVIG) relapse at a higher frequency than those treated with plasma exchange (PE), 54 patients with GBS were studied retrospectively. A higher frequency of relapses was noted in the PE-treated patients than in those receiving IVIG. The presence of an associated medical condition correlated with an increased risk of relapses, while earlier onset of treatment resulted in a decrease of relapses of GBS. This study found no support for prior suggestions of increased relapses in patients with GBS treated with IVIG as opposed to those treated with PE.

KW - Guillain-Barre syndrome

KW - Intravenous immune globulin

KW - Plasma exchange

KW - Relapses

UR - http://www.scopus.com/inward/record.url?scp=0031723490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031723490&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-4598(199810)21:10<1327::AID-MUS14>3.0.CO;2-Z

DO - 10.1002/(SICI)1097-4598(199810)21:10<1327::AID-MUS14>3.0.CO;2-Z

M3 - Article

C2 - 9736064

AN - SCOPUS:0031723490

VL - 21

SP - 1327

EP - 1330

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

IS - 10

ER -